Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

Johanne Silvain, Benoît Lattuca, Farzin Beygui, +195

The Lancet

Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseMedicineCardiovascular Pharmacology +8

Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement

Sylvain Beurtheret, Nicole Karam, Noémie Resseguier, +37

Journal of the American College of Cardiology

Clinical Implications of Very Low On-Treatment Platelet Reactivity in Patients Treated With Thienopyridine

Thomas Cuisset, Charlotte Grosdidier, Anderson Diendonné Loundou, +9

JACC: Cardiovascular Interventions

ThrombopoiesisThrombosisClinical ImplicationsPatients TreatedBlood Platelet +5

Effect of CYP2C19*2 and *17 Genetic Variants on Platelet Response to Clopidogrel and Prasugrel Maintenance Dose and Relation to Bleeding Complications

Charlotte Grosdidier, Jacques Quilici, Marie Loosveld, +12

The American Journal of Cardiology

ThrombopoiesisThrombosisBleeding ComplicationsGenetic VariantsCardiovascular Disease +10

Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment

Gilles Lemesle, Marc Laine, Mathieu Pankert, +8

JACC: Cardiovascular Interventions

Optimal TimingNon-pharmacological InterventionPatient SafetyTreatment OptionPharmacotherapy +3

Impact of Obesity and the Metabolic Syndrome on Response to Clopidogrel or Prasugrel and Bleeding Risk in Patients Treated After Coronary Stenting

Mathieu Pankert, Jacques Quilici, Anderson Diendonné Loundou, +11

The American Journal of Cardiology

ObesityPercutaneous Coronary InterventionMetabolic SyndromeThrombosisPatients Treated +11

Usefulness of High Clopidogrel Maintenance Dose According to CYP2C19 Genotypes in Clopidogrel Low Responders Undergoing Coronary Stenting for Non ST Elevation Acute Coronary Syndrome

Thomas Cuisset, Jacques Quilici, William Cohen, +8

The American Journal of Cardiology

Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseAtherosclerosisPharmacology +8

Comparison of Platelet Reactivity and Clopidogrel Response in Patients ≤75 Years Versus >75 Years Undergoing Percutaneous Coronary Intervention for Non–ST-Segment Elevation Acute Coronary Syndrome

Thomas Cuisset, Jacques Quilici, Charlotte Grosdidier, +7

The American Journal of Cardiology

Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseBlood PlateletHematology +8

TicagRelor Or Clopidogrel in severe or terminal chronic kidney patients Undergoing PERcutaneous coronary intervention for acute coronary syndrome: The TROUPER trial

Marc Laine, Gilles Lemesle, Stéphane Burtey, +8

American Heart Journal

Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseMedicineTrouper Trial +11

Transradial approach and subclavian wired temporary pacemaker to increase safety of alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: The TRASA trial

Thomas Cuisset, Frédéric Franceschi, Sébastien Prévôt, +7

Archives of cardiovascular diseases

Transradial ApproachCardiomyopathyTrasa TrialDevice TherapyMedicine +4